Recent technological advances provide new tools to manipulate cells and biological agents in micro/nanoliter volumes. With precise control over small volumes, the cell microenvironment and other biological agents can be bioengineered; interactions between cells and external stimuli can be monitored; and the fundamental mechanisms such as cancer metastasis and stem cell differentiation can be elucidated. Technological advances based on the principles of electrical, magnetic, chemical, optical, acoustic, and mechanical forces lead to novel applications in point-of-care diagnostics, regenerative medicine, in vitro drug testing, cryopreservation, and cell isolation/purification. In this review, we first focus on the underlying mechanisms of emerging examples for cell manipulation in small volumes targeting applications such as tissue engineering. Then, we illustrate how these mechanisms impact the aforementioned biomedical applications, discuss the associated challenges, and provide perspectives for further development.
Introduction
This review focuses on emerging micro-and nano-scale bioengineering and biomedical microfluidic technology platforms at the convergence of engineering, biology and materials science with an emphasis on broad biotechnology applications in medicine. Strategies have been sought to manipulate cells spatially to develop a better understanding of living systems. 
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A broad range of technologies driven by numerous mechanisms such as fluid mechanics, [1] [2] [3] chemical affinity, 4 magnetic, [5] [6] [7] [8] electrical, [9] [10] [11] optical, [12] [13] [14] [15] and acoustic fields 16, 17 have been presented to manipulate cells and provide potential solutions to diseases. For instance, achieving high cell density and structural complexity is of great importance for engineering artificial tissues.
With broad applications of hydrogels in regenerative medicine and biomedical research, 18 manipulating cell-encapsulating hydrogels via non-invasive external fields has emerged as a method to construct tissue models through a bottom-up engineering approach. 19 Bioprinting different cell types is another approach to create functional tissue constructs. 20, 21 The ability to encapsulate and pattern single cells at physiologically relevant cell densities would allow engineering of complex tissue structures in vitro. 18, 22 Creation of in vitro three-dimensional (3-D) functional tissue constructs mimicking the role, micro-architecture, and functional properties of native biological systems and human tissues could potentially reduce pre-clinical testing on animals. 19, 23, 24 Costeffectiveness of gathering clinically relevant information is significantly improved through in vitro multivariate testing systems (e.g., cell microarrays for drug screening) due to reduced reagent consumption and increased mass exchange rates between cells and their microenvironment. 23 With high-density microwells on a chip, isolation of single cells is achievable, which can be explored to elucidate the underlying mechanisms of cancer pathogenesis and metastasis, as well as to screen drug candidates at high throughput. 23 Approaches for manipulating cells in micro/nano-scale volumes have been widely explored to improve point-of-care (POC) testing. Isolation of cells from whole blood (e.g., circulating tumor cells (CTCs) for cancer research, 25 cluster of differentiation 4 positive (CD4 + ) T-lymphocytes for human immunodeficiency virus (HIV) monitoring [26] [27] [28] ) has been demonstrated using microfluidic systems via immuno-capture by antibodies specific to cell surface proteins. 26, [28] [29] [30] Because of their versatility and affordability, these devices can be used at primary care settings to facilitate clinical decisions. On the other hand, selective capture and on-demand release of stem cells in microfluidic channels provide an attractive alternative to enrich rare cells from complex biological samples, thus creating the possibility for downstream proteomic and genomic analyses. 29, 30 Here, we present state-of-the-art technologies employed to manipulate cells at the micro-scale level for applications in medicine. This review aims to provide a comprehensive overview with a broad perspective in physics, biology, engineering and medicine by highlighting the most significant approaches to date in cell manipulation for widespread applications. We provide examples focusing on clinical applications that were enabled by these technologies from a broad range of fields including diagnostics, regenerative medicine, reproductive medicine, and biopreservation. Although these fields seem to be apart from each other, we underline how they have been impacted by these emerging micro/nano-scale technologies sharing the same core competencies enabled by our evolving technological ability to command cells and their microenvironment in micro/nano-scale volumes.
Theories for modelling cell manipulation
There are several methods based on magnetic, optical, electrical, and mechanical principles to manipulate cells 31 (Table 1) .
For instance, magnetic particles can be selectively attached to cells for cell separation or purification in microfluidic devices.
There is a growing interest in optical tweezers for parallel, noncontact, and contamination-free manipulation of cells. 32, 33 Manipulation of target cells can also be achieved by microfabricated structures such as microfilters, 34 microwells, 35 microgrippers, 36 dam structures, 37 and sandbag structures. 38 Electrical forces can be employed through electrophoresis and dielectrophoresis to manipulate cells. Dielectrophoretic forces arise from polarizability of cells, while electrophoresis arises from the interaction of cell charges and an electric field.
39,40
Here, we describe underlying mechanisms for a set of emerging techniques 41 where cell-encapsulating femto-to-nano-liter hydrogels are assembled and/or patterned into complex geometries for applications including tissue engineering. 
Electrical:
39 Dielectrophoresis (DEP) is the motion imparted on uncharged particles due to polarization when subjected to a non-uniform electric field. DEP is the electronic analog of optical tweezers.
High efficiency, high selectivity, parallel manipulation.
Low survival rate of cells, complex instrumentation.
Chemical:
26,28-30,130 Antibody immobilization onto microfluidic channels.
High selectivity and high capture efficiency.
Chemical waste disposal, specific antibody development, lengthy procedure for antibody immobilization.
Mechanical:
34-38 Separation of target cells can be achieved by microfabricated structures. Advantages and disadvantages are separately written in the next columns for: (1) size-dependent filter-based microfluidic devices; (2) microgrippers; (3) dam and sandbag structures.
(1) High labeling efficiency, short detection time, high reproducibility based on simple and robust experimental procedures, high detection sensitivity at cell level; (2) manipulation of single cells with minimal damage; (3) relatively easier fabrication, and can efficiently immobilize cells with minimal stress.
(1) Poor selectivity; (2) Complex fabrication procedures, poor selectivity; (3) Poor selectivity.
Optical:
32,33 Biological molecules can be tethered to dielectric spheres, which can be captured at the focal point of an electric field gradient.
High-resolution, non-contact, contamination-free.
Limited manipulation area, complex optical setup, complex operation, and expensive instrumentation.
Applications in tissue engineering and regenerative medicine
Magnetic assembly: 7, 8 Magnetic field gradients can be employed to actuate magnetic nano-particle (MNP) and/or free/stable radical-encapsulating hydrogels.
Non-contact, contamination-free, high throughput, low adverse effects on cells, high spatial resolution.
Although there are FDA approved magnetic particles and their release from micro-scale hydrogels are proven, 233 release from large assembled tissue constructs has to be proven.
Acoustic assembly:
16 Acoustic fields can be used to agitate the liquid surface where cell-encapsulating hydrogels assemble.
Non-contact, contamination-free, high throughput, low adverse effects on cells, low complexity.
Low spatial resolution.

Surface tension driven assembly:
4 Tendency of multiphase liquid-liquid systems to minimize the surface area and to reach a lower energy configuration is used.
Low complexity.
Low spatial resolution, low throughput.
Microfluidic assembly: [234] [235] [236] Microfabricated fluidic channels can be used as rails to transport hydrogel blocks.
High spatial resolution, low adverse effects on cells.
Complex fabrication, low throughput.
Ratchet assembly:
237 Unidirectional surfaces offer to assemble cell-encapsulating microgels via sequential assembly processes.
Low adverse effects on cells.
Complex fabrication procedures.
Bioprinting: Several bioprinting methods based on acoustic, 17, 79 inkjet, 80, 81 valvebased, 47, 78, 82, 83 and laser printing 13, 22, 84 technologies have been used to manipulate cell-encapsulating hydrogels.
High spatial resolution, high throughput.
High complexity, medium potential adverse effects on cells, medium cell density.
leveraging magnetic levitation. 57 Magnetic nanoparticles (MNPs) have been utilized to create two-dimensional (2-D) surface patterns, 43, [58] [59] [60] as well as 3-D cell culture arrays 61 and characterize cell-membrane mechanical properties. 62 In these magnetic methods, cells were first mixed directly with ferrofluids or functionalized MNPs, and then exposed to external magnetic fields, allowing controlled manipulation. Besides, methods to encapsulate MNPs in hydrogels have been developed based on microfluidics 51, [63] [64] [65] and applied to multiplexed bioassays, e.g. rapid sensing of nucleic acids. 66 Assembly of cell encapsulating micro-scale hydrogels has been performed by utilizing MNPs (Fig. 1) . 7 Gels were also shown to present paramagnetic properties without MNPs due to formation of free radicals during photocrosslinking. 8 These hydrogels were directed on a fluid reservoir by using a permanent magnet. 8 Magnetic transport of hydrogels can be affected by several factors including: (i) viscous drag, (ii) hydrogel-fluid interactions (agitations to the flow field), (iii) gravitational field, (iv) buoyancy force due to density difference, and (v) thermal effects. Here, it is assumed that the active forces are the magnetically-induced forces and fluidic drag forces. The motion of cell-encapsulating hydrogels can be modeled using Newton's law,
where m and v m are the mass and velocity of the hydrogel, and F m and F f are the magnetic and fluidic drag forces, respectively. The magnetic force on a magnetized hydrogel by utilizing MNPs can be written as,
where V and M are the volume and magnetization of the hydrogel, respectively and H is the applied magnetic field. The fluidic drag force is approximated using Stokes' law for the drag on a sphere,
where Z and v m are the viscosity and the velocity of the hydrogel, respectively. Using these active forces, kinematics of floating hydrogels can be predicted, 8 and assembly performance can be evaluated and improved.
Capillary driven manipulation of cell-encapsulating hydrogels
Lateral capillary forces were utilized for assembly of cell encapsulating micro-scale hydrogels, 4 and evaluated mathematically to assess the limitations that the size of objects imposes on the assembly process. 67 The assembly of two objects at the interface of two fluids (e.g., air and mineral oil, 4 or two liquids 67 ) can be evaluated by calculating the change in interfacial free energy. As two surfaces move from infinite separation to some finite separation, d (Fig. 2) , the height h of the interface between the two objects can be calculated using the linearized Laplace equation:
where g is the interfacial free energy, Dr is the density difference between the two fluids, g is the gravitational acceleration, and DP 0 is the change in pressure across the interface at x = 0. The solution of eqn (4) 
where x c can be set as the capillary length (g/Drg) 1/2 . The interfacial energy can be calculated as a function of distance between objects. The alteration in interfacial free energy, DW, can be set to 5Dlgt (Fig. 2) . 67 Results showed that interfacial free energy for capillary self-assembly is favorable for flat objects with thickness as small as 100 nm (Fig. 2) . 67 For 2-D assembly of spherical objects, the radius of object at which interfacial free energy is close to thermal energy (kT) has been calculated to be on the order of 1 to 10 mm. 
Bioprinting cell encapsulating droplets
Droplet generation techniques based on microelectromechanical systems (MEMS) have been originally developed for applications in semiconductor industry. [70] [71] [72] [73] [74] [75] [76] [77] To address the needs in complex tissue engineering applications, these techniques have also been used for cell encapsulation 17, 78 and patterning (Fig. 3) . 17, 21, 78 instance, cell-encapsulating picoliter droplets were acoustically generated from an open-pool without a nozzle, which eliminates challenges associated with nozzle shear or clogging (Fig. 4 ). These devices can eject a broad range of materials including viscous polymers, fluids and cells simultaneously from the same ejector array. Further, they offer micro-scale precision over the cell position with droplet directionality. Picoliter to nano-liter droplets (as small as 3-200 mm in diameter) can be generated with acoustic patterning technologies. 76, 85 Bioprinting can be divided into two steps: (i) formation of cell-encapsulating droplets from cell suspension, and (ii) impact and subsequent relaxation of droplets on the receiving surface. Cell encapsulation is a highly probabilistic phenomenon as there are several governing parameters such as cell density and cell distribution in suspension. Statistical methodologies can provide a better understanding of the cell encapsulation process. A reliable and repeatable control can be gained over the parameters that characterize the cell encapsulation process. For several target cell concentrations and types of cell loading, the encapsulation process was statistically analyzed. 86 As shown in Fig. 5A -C, while the percentage of target cells and homogeneity decreased in cell suspension solutions, the encapsulation probability of a target cell P(X t ) decreased. More recently, a statistical model based on negative binomial regression has been also presented to demonstrate how (i) cell concentration in the ejection fluid, (ii) droplet size, and (iii) cell size affect the number of cells encapsulated in an ejected droplet. 87 Similarly, for cell deposition, computational models enable researchers to develop an understanding of how parameters such as ejection speed and viscosity of cell suspension affect cell viability. [88] [89] [90] Mechanical factors, e.g., shear stresses, hydrodynamic pressures, capillary forces, may amplify and cause deformation of cells. These factors can be controlled experimentally by adjusting ejection speed or by replacing cell suspension fluid with those having material properties (e.g., viscosity, density, and surface tension) that lead to less shear stress on cells. Cell viability also depends on receiving surface characteristics such as hydrophobicity, roughness, and elasticity of the surface. Prediction of cell deformation and viability via computational methods can be complementary to fulfil several design goals for building complex viable tissue constructs. A finite difference front tracking model was developed to model the deposition of viscous compound droplets (i.e., a smaller droplet encapsulated in a larger droplet) onto a receiving surface as a model for a cell printing process 89, 91 ( Fig. 5D-F ). In this work, the settings that result in least cell deformation and the smallest rate of deformation were identified. The analyses were performed for a set of nondimensional numbers, i.e., Reynolds number (Re), Weber number (We), viscosity ratio
and equilibrium contact angle (y e ). ''Re'' and ''We'' are nondimensional numbers in fluid mechanics to evaluate the ratio of inertial forces compared to viscous forces and surface tension, respectively. The computational results demonstrated that cell deformation gradually increased as:
On the other hand, a local minimum, at least, of maximum geometrical deformation was obtained at We = 2. Cell viabilities were linked to cell deformation by employing an experimental correlation of compression of cells between parallel plates 92 ( Fig. 5F ). Results showed that y e and m c /m d were highly correlated with cell viability.
Applications of micro-scale manipulation of cells
Diagnostic applications
The capability of manipulating cells (e.g., capture/isolation) at the micro-scale level, in combination with rapid detection technologies, creates the potential for inexpensive, portable and disposable devices for POC testing. Particularly, there is an urgent need for such diagnostic tools in resourceconstrained settings where well-trained technicians, basic laboratory infrastructure and sustained financial support are not available. 28, 93, 94 Additionally, patients would benefit from rapid healthcare technologies similar to rapid glucose tests. Such tests can enable close monitoring of patients suffering from a broad range of diseases ranging from renal diseases to infectious diseases such as HIV. Microfluidic technologies for cell manipulation in micro-scale volumes have enabled new approaches to monitor and detect various diseases. Here, we focus on (i) CTC capture and detection, (ii) CD4 + T lymphocyte count in blood, (iii) pathogen detection and cancer biomarker detection, and (iv) sperm monitoring and sorting. 3.1.1. Capture/detection of CTCs in microfluidic devices. Cancer related deaths account for approximately 13% of all deaths each year, 95 primarily due to metastasis of CTCs in distant organs and subsequent metastatic diseases. 96 As such, isolation of rare CTCs (at a ratio of one cell per 10 9 blood cells) from whole blood can potentially achieve cancer detection and reduce cancer-related mortality, as well as provide target cells for molecular characterization, drug screening and treatment monitoring. Earlier, antibody coated magnetic beads have been used to develop a system to isolate and quantify CTCs from blood using the CellSearch System (Veridex LLC, Raritan, NJ). 97 Microfluidic devices have adapted this antibody-based isolation approach to isolate and enrich CTCs from peripheral blood. 25, 98, 99 Generally, microfluidic based approaches rely on the interactions between proteins on the surface of CTCs and corresponding ligands immobilized in microfluidic devices. Depending on the downstream applications, captured cells onchip are subsequently subject to immunostaining and molecular analyses to provide biological insights into metastasis and to identify new biomarkers for anti-cancer treatment monitoring. For example, isolation of CTCs from whole blood using a microchip was reported. 25 This microchip consists of microposts and the microchannel surface is coated with an antiEpithelial cell adhesion molecule (EpCAM). On the surface of CTCs, the adhesion protein EpCAM is up-regulated compared to healthy blood cells. Under the optimal flow conditions, CTCs from metastatic lung, prostate, pancreatic, breast and colon cancer patients were captured on-chip due to the difference in the expression level of EpCAM. 25 The captured CTCs were subsequently immuno-stained for confirmation. Under controlled laminar flow conditions, the authors achieved capture efficiency of approximately 60% at a flow rate of 1-2 mL per hour and a purity of around 50%. With the advantage of continuous flow, this technology detected CTCs from 115 patients out of 116 in a study, indicative of the potential for management of cancer at clinical settings. This technology has been further developed by integrating an automated quantitative imaging system, which improved the analytical throughput. 99 In addition to immunocapture, physical characteristics have been utilized for isolation of CTCs. CTCs are generally softer and more deformable than healthy cells, 100 which allows the detection of carcinoma cells using impedimetric transducers to measure the increase in volume of cancer cells under hypsometric pressure. 101 Alternatively, the size differences between cancer and benign cells can also be used to detect CTCs, based on conductance measurements. 102 These methods allow detection of cancer cells from whole blood without pre-labeling, potentially realizing serial monitoring of anti-cancer therapy at the primary care settings in the future. 
17,71
Captured CTCs can also be coupled with molecular techniques to monitor the regulation of protein expression that is associated with cancer metastasis. For example, the overexpression of epidermal growth factor receptor gene (EFGR) has a high correlation with cancer metastasis. 103 In a small cohort study, genomic analysis of those isolated CTCs from non-small-cell lung cancer patients was performed. 98 It was observed that the number of isolated CTCs was highly correlated with therapeutic responses and/or tumor progression. Particularly, the emergence of EGFR mutations was identified in some cases with progressive tendency. Constant molecular monitoring of cancer patients receiving treatment has potential to provide valuable information on prognostics and treatment efficacy. These algorithms enabled 100 times faster outcomes than manual counting for the fluorescent stained cells, especially when a large number of cells are present in the microchannels on the order of thousands. These approaches significantly increase the efficiency and accuracy to obtain CD4 + cell count.
However, it should be noted that the need for a fluorescence microscope is not practical for POC testing in resourceconstrained settings. To address this barrier, new technologies were developed including shadow-based lensless imaging, [26] [27] [28] 112, 115 electrical sensing of lysed cells after isolation 116 integrated with microfluidic chips where the cells were selectively captured. These advances led to point-of-care microfluidic detection methods that provide a CD4 + count using fingerprick volume of whole blood without any sample preprocessing steps. 26 Specifically, to suit the need in resourcelimited settings, label-free detection and counting strategies have been developed using light microscopy, impedance measurements and lensless imaging. In an initial effort, a light microscope was used to count captured CD4 + cells in a microfluidic device which involves a tedious manual counting step. 117 To overcome this drawback, a rapid CD4 + cell counting method was developed using impedance measurement. 118 This method eliminated the need for a fluorescence microscope and significantly shortened the quantification time as required in manual counting, which can be potentially implemented at the POC settings. Recently, CD4 + cell counts can be obtained using a lensless, ultra wide-field cell array based on shadow imaging (LUCAS) (Fig. 6) , 112 which enables rapid CD4 + cell counting within 10 minutes. 27 Further, the LUCAS system has been validated in Tanzania with clinical samples and the results show positive correlation with the gold standard, i.e., flow cytometry, showing the potential of pairing with POC testing to facilitate clinical on-site decision-making. 26 3.1.3. Microfluidics based POC applications. Similarly, microfluidic devices can also be used to detect multiple pathogens such as bacteria and viruses as well as smaller molecules such as proteins, demonstrating the versatility for developing POC assays in a miniaturized format. For example, microchips have been developed to selectively capture E. coli from various samples such as whole blood, phosphate buffered saline (PBS), milk, and spinach. 119 This method can be used to monitor potential food poisoning and open wound infections without using conventional bacterial detection methods such as agar plate culture or polymerase chain reaction, as these conventional methods are time-consuming and instrumentdependent. In addition, agar plating, the gold standard for bacterial detection, requires 48 to 72 hours to complete, 120 and it is often associated with false negative results ranging from 7.2 to 21.2%. 121, 122 The immuno-based microchip captured E. coli via lipopolysaccharide binding protein with a detection limit of 50, 50, 50, and 500 CFUs per mL in PBS, blood, milk, and spinach samples, respectively. The presented technology can be broadly applied to detect other pathogens, creating new avenues for POC diagnosis and monitoring of infectious diseases. Enabled by the reliable immuno-capture of pathogens in microfluidic devices, this technology was extended to address the urgent need for developing rapid HIV viral load assays, which is essential to diagnose early HIV infection and monitor AIDS patients on antiretroviral therapy (ART). 94 Also, HIV viral load assays can be used to prevent mother to child transmission (MTCT), since traditional immunoassays cannot reliably detect HIV infection in infants until the age of 18 months due to passively transferred maternal antibodies. 123 Previously, an on-chip detection method was developed to selectively capture HIV from 10 mL unprocessed HIV-infected patient whole blood. 124 The method leveraged the photo-stability of quantum dots (Qdots) and tagged the captured HIV particles with dualcolor labeling. Two types of Qdots (Qdot525 and Qdot655) were used to label envelope glycoprotein gp120 and high-mannose glycans for dual-staining. Recently, the on-chip capture mechanism was used to capture various HIV subtypes 125 that are dominant in developing countries and constitute a significant 40 Additionally, microfluidic devices can be used to miniaturize conventional laboratory-based detection methods such as ELISA to detect protein biomarkers. 129, 130 For instance, ovarian cancer is asymptomatic at the early stages and it often leads to a poor 5 year survival rate of 33% at stages III and IV, when patients present with symptoms. 131 To address the urgent need for ovarian cancer detection, an ELISA microchip was developed to detect human epididymis protein 4 (HE4) from urine. 130 The microchip ELISA results were detected using a cell phone via integration of a mobile application that reports the concentration of HE4 on a phone screen (Fig. 7 ). As shown, the level of HE4 in urine samples from cancer patients (n = 19) detected was significantly elevated than the healthy controls (n = 20) (p o 0.001). Receiver operating characteristic (ROC) analyses showed that the microchip ELISA had a sensitivity of 89.5% at a specificity of 90%. This approach offers a quantitative ELISA test using a simple cell phone based colorimetric detection instead of an expensive, bulky spectrophotometer, thus potentially offering an attractive POC platform. In addition, the use of multi-channel microfluidic design allows detection of multiple biomarkers simultaneously, as well as the control. 3.1.4. Microfluidic based sperm monitoring and sorting for reproductive medicine. 6.1 million American couples (approximately 10% of American couples of childbearing age) are affected by infertility. 132 Male originated issues are reported in almost half of the infertility cases, which require evaluation of parameters defining sperm quality, such as motility and sperm count. To address male based infertility issues, in vitro fertilization (IVF) with or without intra cytoplasmic sperm injection (ICSI) has been the most preferred assisted reproductive technology (ART) in clinics. One of the challenges of IVF and ICSI is identification and isolation of the most motile and the healthiest sperm from semen samples that have poor sperm counts (i.e., oligozoospermia) and/or poor motility (i.e., oligospermaesthenia). The applications of micro/nano-scale technologies to reproductive medicine have been explored. 115, [133] [134] [135] [136] [137] Microfluidic technologies have been employed to separate motile sperm with a higher efficiency compared to conventional sperm sorting techniques. 115, [134] [135] [136] [137] [138] [139] A microfluidic device with an outlet junction was developed to separate motile sperm from directionally moving non-motile sperm. 138 More recently, a lensless imaging system was integrated with a microfluidic chip to achieve automatic and wide field-of-view (FOV) imaging of a small population of sperm inside a microfluidic channel (Fig. 8 ).
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Using a lensless charge-coupled device (CCD) system, sperm swimming inside a channel were directly imaged as shadow patterns and sperm movements were tracked (Fig. 8) 27, 112 These systems could be used to record sperm over an entire channel and even in multiple parallel or serial channels. As the sperm is known to be responsive to gravitational stimuli, 140 sperm motion in both horizontal and vertical microchip configurations was recorded, and results were displayed in bull's eye plots presenting the sperm movement on chip (Fig. 8L) . In both configurations, sperm displayed great diversity in their patterns of motion and direction. The swimming paths were tracked and the kinematic parameters that define sperm motility, including average path velocity (VAP), straight-line velocity (VSL) and straightness (VSL/VAP) were quantified (Fig. 8M) . and Straight Line Velocity (VSL) of sperm for non-sorted conditions, and at the inlet and outlet of the 7 mm long microfluidic channel. The VAP and VSL were observed to be significantly greater for the sperm cells imaged at the outlet of the microfluidic channel compared to non-sorted sperm and the sperm at the inlet. Therefore the microfluidic sperm tracking system presented here shows potential to be also used as a sorting platform (n = 33-66, brackets indicate statistical significance with p o 0.01 between the groups). Reproduced with permission.
VAP refers to the average distance that a sperm covers in the direction of movement per unit time. VSL is the ratio of the straight-line distance between the start and end points of a sperm trajectory to the elapsed time until the sperm reaches the end point. Sperm were tracked in both horizontal and vertical configurations and the motilities were measured. The microfluidic channels create an environment that mimics the natural swim paths of sperm. Under real physiological conditions, sperm move through the vaginal mucus, cervical mucus and the cervical canal similar to a microfluidic channel. Once the mucus on the vaginal surface transforms into a less viscous watery phase, microchannels are formed. Such a space constrained microenvironment (i.e., the length scale in the flow direction is significantly larger than that in other directions) directs sperm towards the oocyte along with other contributing factors such as chemotaxis. 115 To demonstrate microchipbased sperm sorting, sperm motilities at the outlet and inlet were compared to that of non-sorted sperm controls. As shown in Fig. 8M , sperm motility at the outlet was significantly higher than those of non-sorted sperm (p o 0.01), indicating that the microchip can be used to sort the most motile sperm, which can then be collected from the outlet. In addition, given the wide range of sperm velocities even after sorting, single cell based processing and monitoring enables separation of highest quality motile sperm from the rest utilizing either vertical or horizontal configurations. Recently, the exhaustion of mouse sperm (30 min) and human sperm (>1 hour) were quantitatively demonstrated and experimentally validated using microfluidics as an enabling technology. 141 
Applications in isolation, purification, and enrichment of cells
Isolation, purification and enrichment of rare and specific target cells from heterogeneous populations and manipulation of cells in micro-scale volumes have enabled advancement of fields such as: cell based diagnostics, 27, 29, 117 genomic and proteomic analyses, 25, 142, 143 clonal and population studies, 144, 145 stem cell isolation for tissue engineering, 29, 30, 146, 147 and circulating tumor cell isolation for cancer research. 25, 148 Fluorescence-activated cell sorting and magnetic-activated sorting are commonly used cell manipulation technologies for isolation, which require preliminary processing and labeling of cells with fluorophore or magnetic particle conjugated antibodies. While these methods are powerful and successfully separate cells from heterogeneous mixtures, the cost, complexity and requirements for infrastructure (e.g., facility and reagents) limit their use. 149 Miniaturization of these systems has been attempted by reducing them to simpler microfluidic versions. 150, 151 However, the required peripheral equipment still remains large in size and costly. Furthermore, genomic studies on captured cells in microfluidic systems are mainly hampered by the loss of genomic material, which can adhere to the channel walls due to the large surface to volume ratio. These limitations can be addressed by the release and downstream processing of captured cells in microfluidic channels through manipulation in micro-scale volumes. 29, 30 Release of the selectively captured live cells (e.g., CTC, CD4 + , CD34 + , endothelial cells) in micro-scale volumes would enable post-culturing, clonal and molecular characterization studies. However, challenges remain in effectively releasing the captured cells in microfluidic channels without compromising the viability of the captured cells. [152] [153] [154] To minimize adverse effects on cells, manipulation and recovery of the captured cells need to be performed without using chemical or physical factors, which can affect cellular characteristics. For example, using enzymatic or fluid shear based detachment is known to adversely affect cell viability and function. 155, 156 Alginate based hydrogels have recently been used in combination with poly(ethylene glycol) and conjugated antibodies in microfluidic channels to capture endothelial progenitor cells from blood. 157 The captured cells were then released by dissolving the hydrogel in the channels with a chelator, e.g., ethylenediaminetetraacetic acid (EDTA). Alginate hydrogels, however, allow a high level of non-specific binding 154, 158 and offer limited numbers of sites for the conjugating antibodies, which significantly reduce the capture efficiency. 157 Furthermore, coating and chelation of hydrogels in microfluidic channels add extra steps and cost, lengthy processing time, operational complexities and additional reagents, which render this approach challenging to apply, especially at the bedside or resource-constrained settings.
Most of the downstream applications of cell capture require the captured cells to be lysed on-chip for genomic and proteomic analysis. However, cellular materials are lost to the microchannel surfaces due to the large surface to volume ratio. Additionally, in most cases the captured cells are so rare in concentration that they need to be expanded over culture for following biological analysis steps. Hence, manipulation and release of captured cells in microfluidic channels is a significant enabling biotechnology with broad applications. It was previously shown that poly(N-isopropylacrylamide) (PNIPAAm) coated surfaces interact strongly with peptides and proteins (e.g., insulin chain A, serum albumin) above lower critical solution temperature (LCST). 159, 160 Whereas, when the temperature of the surface is reduced below the LCST, a complete desorption of the adsorbed proteins is possible. 159, 160 It was shown that the protein adsorption-desorption mechanism on a temperature-responsive polymer (PNIPAAm) 160 can be modified to develop a biotin-binding protein and biotinylated antibody based surface chemistry to rapidly and selectively capture and controllably release cells on-demand in microfluidic channels. 29, 30 Thermoresponsive microfluidic channels were developed by functionalizing surfaces with biotin-binding protein and biotinylated antibody that can selectively capture specific cells from blood and controllably release with high viability and specificity, which provide a new platform to manipulate cells in micro-scale volumes (Fig. 9 ). More recently, a microfluidic system with sufficient micro-scale control to locally release a selected set of captured cells on-chip would significantly increase specificity (Fig. 10) . 30 As microfluidic cell capture methods suffer from non-specific binding events, being able to manipulate and selectively release the undesired or desired 163, [188] [189] [190] Even though these methods are commonly used, scaffold-based technologies face challenges in precisely patterning cells in specific architectures to form highly organized and high cell density tissue constructs. Stepwise brick-by-brick building block techniques constitute an alternative approach to build 3-D tissue constructs. 190 In this approach, 3-D tissue structures are built by using micro-scale hydrogels (200-500 mm in size). Various bioprinting methods have been developed to control cell seeding in 2-D and 3-D settings, such as inkjet and laser printing 21, 80, 81, 191 to gain control over the spatial cellular and ECM composition, cell viability and functionality, and spatial density. 192 Cell manipulation technologies in micro-scale volumes can have a clinical impact on medicine, such as in cardiac and neural tissue regeneration. Cardiovascular diseases affect 70 million Americans, resulting in an economic burden of $300 billion and accounting for nearly 40% of all deaths in the US. 18 Conventional treatments of cardiac injury cannot achieve myocardial regeneration. Engineered cardiac tissue grafts can be surgically placed into the defect site to facilitate cardiac regeneration. 18 Additionally, neurodegenerative diseases, [193] [194] [195] [196] such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), Amyotrophic lateral sclerosis (ALS), and Traumatic brain injury (TBI), lead to impairment of the neural system, loss of cognitive abilities, and permanent paralysis. Currently, there is no effective treatment for neurodegenerative diseases, or brain and spinal cord injuries. 197, 198 Neural tissue is extremely complex, contains many different cell types with connections forming an intricate 217 and has emerged as a potentially ideal alternative method because of the higher survival rate by eliminating ice crystal formation. However, high levels of CPA (e.g., 6-8 M) have to be used for rapid freezing necessary for vitrification (e.g., À1500 1C min À1 ), which may also cause uncontrolled differentiation and smaller viability of cells. [218] [219] [220] Integration of nano-liter droplet cell encapsulation technologies with vitrification is promising. [221] [222] [223] Single to few cells encapsulated in droplets can be directly ejected into a liquid nitrogen reservoir utilizing bioprinting technologies for vitrification. These droplets can also be placed on a thin film and then directly dipped into liquid nitrogen. 224 This process enables minimized CPA volumes for vitrification, and, hence, benefits from enhanced warming and cooling rates due to the larger surface to volume ratio. Moreover, biopreservation technologies may need to achieve processing of large sample volumes at high-throughput to enable clinical relevance and practical use. For instance, the cryopreservation of blood is of great importance to public health during natural disasters, global issues, warfare, and in clinical settings due to fluctuations in supply and demand. 225 Also, the existing approaches employing high CPA concentrations may require tedious manual steps during handling of cells between CPA loading and unloading solutions. Therefore, integration of nano-liter cell encapsulation technologies with vitrification can reduce manual steps, handling errors and operator variability. Recently, a droplet ejection technology was developed to vitrify oocyte encapsulating nano-liter droplets. 226 This platform was utilized to vitrify and cryopreserve oocytes, which were encapsulated in nano-liter droplets at high-throughput. 226 During this vitrification process, morphologies of the mouse oocytes, their parthenogenetic development, and survival rates were compared to fresh oocytes cultured in the potassium simplex optimized medium (KSOM) right after retrieval. Similar survival rates were reported between the results of the droplet encapsulation method and the control group (i.e., fresh oocytes after 24 h in culture). Morphologies of the oocytes and the rate of parthenogenetic activation were also comparable between the oocytes collected after vitrification/thawing and the fresh oocytes. Another important application of cryopreservation is blood banking. 224 Recently, RBC encapsulating nano-liter droplets (e.g., radius o 100 mm) were vitrified at high throughput (Fig. 11) . 224 A co-flow droplet ejection system (i.e., nitrogen and RBC flow) was used to generate RBC encapsulating droplets. The effects of the experimental parameters: (1) the RBC flow rate (RBCs were loaded with CPA) (160 to 220 mL min À1 ), (2) the nitrogen gas flow rate (3.2 to 4.8 L min À1 ), and (3) the distance between the ejector tip and droplet receiving film (60 to 90 mm), were evaluated (Fig. 11) . 224 To enable vitrification of RBCs with low CPA levels, nano-liter droplets were created in a continuous manner by adjusting the nitrogen gas flow rate. This approach minimized the possibility of negative osmotic and toxic effects by increasing cooling rates and using a low level of CPAs. 227, 228 On the other hand, stem cells have been clinically essential due to their pluripotent potential and their role in regeneration of damaged tissues. 185 For stem cells, high CPA levels can cause uncontrolled differentiation and smaller viability. 219, 220 Vitrification results in higher viabilities of stem cells compared to other methods including slow freezing. 229, 240 Low CPA-level vitrification in nanoliter volumes has immense potential for stem cells compared to other methods in preserving their functionality. 219, 220, 229 Long-term biopreservation of cells in micro-scale volumes has a broad impact on multiple fields including tissue engineering, regenerative medicine, stem cells, blood banking, animal strain preservation (biodiversity protection), clinical sample storage, transplantation medicine and in vitro drug testing.
Conclusions and prospects
Manipulating cells in small volumes while maintaining viability and biological functionality has been a significant challenge for various applications in medicine. Advanced micro-scale manipulation technologies emerge at the convergence of multiple fields including basic sciences, engineering, and medicine. To address these challenges, several approaches have been developed based on magnetic, electrical, mechanical, acoustic, and fluidic principles. Among these approaches, bioprinting technologies are promising to achieve manipulation of cells and biological agents for applications in drug discovery, drug toxicity and efficacy testing, biopreservation and cancer research. On the other hand, development of microfluidic technologies has enabled miniaturization of traditional methods of manipulating, isolating, detecting and quantifying rare cells and molecules from bodily fluids. Due to simplicity, low cost and portability, microfluidic devices can be utilized widely across many disciplines to manipulate cells and biological agents in micro/nano-scale volumes. However, when a vast number of cells, different cell types and multiple scales are involved, challenges remain to be addressed in high-throughput applications of these technologies. Current challenges in micromanipulation of biological samples are the need for improved speed, flexibility, higher levels of automation, and contact-free operation. These challenges need to be addressed to make them widely available biological tools reducing manual operations without compromising accuracy and cost. To develop widely applicable methods that allow integration of various miniaturized devices on a single system, and parallel processing, a better understanding of microscale manipulation technologies is needed. Further, technologies are needed that have advantages including lower reagent and power consumption, portability, shorter reaction time, and lower cost to manipulate cells in micro-scale volumes. Future studies should also address the need for versatility, ease-of-use, scalability, and highthroughput utilization. These various challenges could be potentially addressed at the convergence of multiple fields.
